🇺🇸 FDA
Patent

US 6262064

Octahydrobenzo[f]quinoline-based receptor agonists and antagonists

expired A61PA61P25/18A61P25/20

Quick answer

US patent 6262064 (Octahydrobenzo[f]quinoline-based receptor agonists and antagonists) held by State of Rhode Island and Providence Plantations expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
State of Rhode Island and Providence Plantations
Grant date
Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P25/18, A61P25/20